SARS-CoV-2 viral load as a predictor for disease severity in outpatients and hospitalised patients with COVID-19: A prospective cohort studyFredrikke Christie Knudtzen, Işık Somuncu Johansen, Thøger Gorm Jensen et al.|PLoS ONE|2021Cited by 42
SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infectionEva Anna Marianne Baerends, M. Ruwald, Astrid Korning Hvidt et al.|iScience|2023Cited by 26
Omicron Variant-Specific Serological Imprinting Following BA.1 or BA.4/5 Bivalent Vaccination and Previous SARS-CoV-2 Infection: A Cohort StudyEva Anna Marianne Baerends, Martin Tolstrup, Joanne Reekie et al.|Clinical Infectious Diseases|2023Cited by 14
Longitudinal Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Immunity Over 2 Years Following Vaccination and InfectionAnna Karina Juhl, S. F. Caspersen, Lisa Loksø Dietz et al.|The Journal of Infectious Diseases|2024Cited by 10
Low mortality of hospitalised patients with COVID-19 in a tertiary Danish hospital settingLone Wulff Madsen, Işık Somuncu Johansen, Line Dahlerup Rasmussen et al.|International Journal of Infectious Diseases|2020Cited by 6